Detection of BCR-ABL1, PML-RARA, CBFB-MYH11, KMT2A-MLLT3, PAX5-AUTS2 and other gene fusions involved in sarcomas or lung cancers. This evidence concerns the gene KMT2A and lung carcinoma.